Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance-Reference-Cited by-同舟云学术

Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance

Published:2018-04 Issue:4 Volume:24 Page:871-876
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Palazzo Meighan,Shah Gunjan L.^ORCID,Copelan Olivia^ORCID,Seier Kenneth,Devlin Sean M.,Maloy Molly,Kenny Sheila,Hassoun Hani,Korde Neha S.,Lendvai Nikoletta,Lesokhin Alexander M.,Mailankody Sham,Chung David J.,Koehne Guenther,Landgren C. Ola,Landau Heather,Giralt Sergio A.,Perales Miguel-Angel

Funder

National Institutes of Health

National Institutes of Health/National Cancer Institute Cancer Center

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference26 articles.

1. Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management;Rajkumar;Am J Hematol,2016

2. Hematopoietic stem cell transplantation for multiple myeloma: guidelines from the American Society for Blood and Marrow Transplantation;Shah;Biol Blood Marrow Transplant,2015

3. Lenalidomide after stem-cell transplantation for multiple myeloma;McCarthy;N Engl J Med,2012

4. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma;Attal;N Engl J Med,2012

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination of Adults With Cancer: ASCO Guideline;Journal of Clinical Oncology;2024-05-10

2. Examining the immunological responses to COVID-19 vaccination in multiple myeloma patients: a systematic review and meta-analysis;BMC Geriatrics;2024-05-08

3. Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation;Bone Marrow Transplantation;2024-02-13

4. Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation;Blood Advances;2023-12-29

5. Facilitators and Barriers to Successful Revaccination after Hematopoietic Stem Cell Transplantation among Adult Survivors: A Scoping Review;Transplantation and Cellular Therapy;2023-11